Charles River Laboratories International Inc (CRL) Analysts | Reuters.com
Edition:
United States

Charles River Laboratories International Inc (CRL)

CRL on New York Consolidated

75.88USD
27 Jun 2016
Change (% chg)

$-4.47 (-5.56%)
Prev Close
$80.35
Open
$80.09
Day's High
$80.11
Day's Low
$75.73
Volume
540,430
Avg. Vol
431,575
52-wk High
$87.95
52-wk Low
$59.99

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.10 December 27 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 6 6
(2) OUTPERFORM 3 3 2 2
(3) HOLD 9 8 8 8
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.35 2.32 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 15 425.64 434.56 417.69 354.67
Quarter Ending Sep-16 15 436.45 445.78 430.40 346.80
Year Ending Dec-16 19 1,655.12 1,666.75 1,607.46 1,394.50
Year Ending Dec-17 20 1,824.83 1,866.00 1,735.89 1,459.33
Earnings (per share)
Quarter Ending Jun-16 18 1.10 1.15 1.08 1.04
Quarter Ending Sep-16 18 1.15 1.18 1.10 0.98
Year Ending Dec-16 20 4.39 4.42 4.34 3.93
Year Ending Dec-17 21 5.01 5.21 4.85 4.20
LT Growth Rate (%) 7 12.15 14.00 8.20 8.03

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 354.91 354.87 0.04 0.01
Quarter Ending Dec-15 349.20 353.85 4.65 1.33
Quarter Ending Sep-15 340.23 349.46 9.23 2.71
Quarter Ending Jun-15 339.59 339.57 0.02 0.00
Quarter Ending Mar-15 323.97 320.41 3.56 1.10
Earnings (per share)
Quarter Ending Mar-16 0.90 0.98 0.08 8.82
Quarter Ending Dec-15 0.94 1.00 0.06 6.39
Quarter Ending Sep-15 0.94 1.03 0.09 9.25
Quarter Ending Jun-15 0.97 0.96 0.01 1.23
Quarter Ending Mar-15 0.82 0.79 0.03 3.89

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 425.64 425.77 425.61 421.86 354.67
Quarter Ending Sep-16 436.45 436.24 436.15 433.38 346.80
Year Ending Dec-16 1,655.12 1,654.80 1,654.59 1,651.19 1,394.50
Year Ending Dec-17 1,824.83 1,827.53 1,827.33 1,821.53 1,459.33
Earnings (per share)
Quarter Ending Jun-16 1.10 1.10 1.10 1.11 1.04
Quarter Ending Sep-16 1.15 1.15 1.15 1.16 0.98
Year Ending Dec-16 4.39 4.40 4.40 4.34 3.93
Year Ending Dec-17 5.01 5.01 5.01 4.97 4.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 1 0
Quarter Ending Sep-16 0 0 1 0
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 0 0 1 0
Earnings
Quarter Ending Jun-16 0 0 1 0
Quarter Ending Sep-16 0 0 0 0
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 0 0 1 0

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.